Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR-MD-02 and Ipilimumab in Metastatic Melanoma
NCT02117362Phase 1Completed
- Start
- May 2014
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial of belapectin in melanoma. Started May 2014; status: completed.
02
Drugs
belapectin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02117362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117362.